期刊文献+

子宫内膜异位症患者腹腔冲洗液及血清CD133、ABCG2的表达 被引量:3

Expression of CD133 and ABCG2 in peritoneal fluid and serum in patients with endometriosis
下载PDF
导出
摘要 目的探讨子宫内膜异位症(EMs)腹腔冲洗液、血清CD133、ABCG2水平与EMs发生发展的关系。方法选择2010年1月~2011年6月江苏省镇江市妇幼保健院收治的EMs患者38例为EMs组,选择同期其他妇科良性病患者22例为对照组。采用酶联免疫吸附试验(ELISA)检测两组腹腔冲洗液及血清中CD133、ABCG2水平并分析其相关性。结果①Ems组腹腔冲洗液CD133、ABCG2水平分别为(13.47±2.37)、(9.81±2.45)ng/L,高于对照组的(11.75±2.82)、(8.14±2.92)ng/L,差异均有统计学意义(P=0.008、0.013)。血清CD133、ABCG2水平分别为(1.39±0.32)、(5.22±1.49)ng/L,高于对照组的(1.13±0.29)、(4.06±1.89)ng/L,差异均有统计学意义(P=0.001、0.006)。②EMs组Ⅲ~Ⅳ期患者腹腔冲洗液CD133、ABCG2水平分别为(14.28±1.99)、(10.55±2.29)ng/L,高于Ⅰ~Ⅱ期患者的(12.35±2.44)、(8.79±2.36)ng/L,差异均有统计学意义(P=0.011、0.027);血清CD133、ABCG2水平分别为(1.53±0.31)、(5.83±1.39)ng/L,高于Ⅰ~Ⅱ期患者的(1.19±0.22)、(4.39±1.21)ng/L,差异均有统计学意义(P=0.001、0.002)。③Ems组腹腔冲洗液CD133、ABCG2水平与血清CD133、ABCG2水平呈明显正相关(r=0.579,P=0.000;r=0.703,P=0.000)。结论腹腔冲洗液、血清CD133、ABCG2升高可能与EMs发生发展有关,有望单独或联合成为EMs诊断的新指标。 Objective To evaluate the expression of CD133 and ABCG2 in peritoneal fluid and serum in patients with endometriosis(EMs).Methods 38 women with EMs from January 2010 to June 2011 in Maternal and Child Hospital of Zhenjiang City were selected as EMs group,22 women with other benign disease of gynaecology and without EMs were chosen as control group.Expression of CD133 and ABCG2 in peritoneal fluid and serum were detected by ELISA,the correlation was analyzed.Results ①The levels of CD133 and ABCG2 in the peritoneal fluid of EMs group were(13.47±2.37),(9.81±2.45) ng/L and they were obviously higher than those of control group [(11.75 ±2.82),(8.14± 2.92) ng/L],the differences were statistically significant(P = 0.008,0.013).The levels of CD133 and ABCG2 in the serum of EMs group were(1.39±0.32),(5.22±1.49) ng/L and they were obviously higher than those of control group [(1.13±0.29),(4.06±1.89) ng/L],the differences were statistically significant(P = 0.001,0.006).②The levels of CD133 and ABCG2 in the peritoneal fluid of the patients with stage Ⅲ-Ⅳ in EMs group were(14.28±1.99),(10.55±2.29) ng/L and they were obviously higher than those of the patients with stage Ⅰ-Ⅱ in EMs group [(12.35±2.44),(8.79±2.36) ng/L],the differences were statistically significant(P = 0.011,0.027).The levels of CD133 and ABCG2 in the serum of the patients with stage Ⅲ-Ⅳ in EMs group were(1.53±0.31),(5.83±1.39),and they were obviously higher than those of the patients with stage Ⅰ-Ⅱ in EMs group [(1.19±0.22),(4.39±1.21) ng/L],the differences were statistically significant(P = 0.001,0.002).③CD133 and ABCG2 levels in serum were found had positive correlation with those in peri toneal fluid(r = 0.579,P = 0.000;r = 0.703,P = 0.000) in Ems group.Conclusion The rise of CD133,ABCG2 in peritoneal fluid and serum may have correlation with the pathogenesis of Ems,it may be a new index in the diagnosis of Ems independently or in combination with other index.
出处 《中国医药导报》 CAS 2013年第24期45-47,共3页 China Medical Herald
基金 江苏省镇江市科技计划项目(编号SH2009019)
关键词 子宫内膜异位症 CD133 ABCG2 腹腔冲洗液 血清 Endometriosis CD133 ABCG2 Peritoneal fluid Serum
  • 相关文献

参考文献21

  • 1Paris K,Aris A. Endometriosis-associated infertility:a decade's tren~ study of women from the Estrie region of Quebec, Canada [J]. Gyneco] Endoefinol, 2010,26 ( 11 ) : 838-842. /.
  • 2Meuleman C, Vandenabeele B, Fieuws S, et al. High prevalence of er dometriosis in infertile women with normal ovulation and normosper mic partner [J]. Fertility and Sterility, 2009,92 ( 1 ) : 68-74.
  • 3Rogers PA, Hooghe TM, Fazleabas A, et al. Defining future directions for endometriosis research:workshop report from the 2011 World Congress of Endometriosis in Montpellier,France [J]. Reprod Sci, 2013,20 ( 5 ) : 483-499.
  • 4Leslie C,Ma T,McElhinney B,et al. Is the detection of endometrial nerve fibers useful in the diagnosis of endometriosis? [J] Int J Gy- necol Pathol, 2013,32 (2) : 149-155.
  • 5Hudelist G,Fritzer N,Thomas A,et al. Diagnostic delay for en- dometriosis in Austria and Germany:causes and possible conse- quences [J]. Hum Reprod, 2012,27 ( 12 ) ~ 34 ! 2-3416.
  • 6Maruyama T,Yoshimura Y. Stem cell theory for the pathogenesis of endometfiosis [J]. Front Biosci, 2012,4 : 2854-2863.
  • 7Kokcu A. Possible effects of endometriosis-related immune events on reproductive function [J]. Arch Gynecol Obstet,2013,287(6):1225- 1233.
  • 8Ballester M, Dehan P,B61iard A,et al. Role of genetic and environ- mental factors in the development of endometriosis [J]. Rev Med Liege, 2012,67 ( 5 -6 ) : 374-380.
  • 9Kao AP, Wang KH, Chang CC, et al. Comparative study of human eu- topic and ectopic endometrial mesenchymal stem cells and the devel- opment of an in vivo endometriotic invasion model [J]. Fertil Steril, 2011,95(4) : 1308-1315.
  • 10Pacchiarotti A,Caserta D,Sbracia M ,et al. Expression of oct-4 and c-kit antigens in endometriosis [J]. Fertil Steril, 2011,95 (3):1171- 1173.

同被引文献32

  • 1Jaiman S, Pochiraju M, Gundabattula SR, et al. Malignant transfor- mation of pelvic endometriosis : case series and review of the literature [ J ]. Int J Surg Pathol,2015,23 (6) :465 - 471.
  • 2Lu Y, Cuellar - Partida G, Painter JN, et al. Shared genetics underly- ing epidemiological association between endometriosis and ovarian cancer [ J ]. Hum Mol Genet,2015 , 24 ( 20 ) : 5955 - 5964.
  • 3Nozawa - Suzuki N, Nagasawa H, Ohnishi K, et al. The inhibitory effect of hypoxie cytotoxin on the expansion of cancer stem cells in o- varian cancer [ J ]. Biochem Biophys Res Commun, 2015,457 ( 4 ) : 706 -711.
  • 4Yan HC, Fang LS, Xu J, et al. The identification of the biological characteristics of human ovarian cancer stem ceils [ J ]. Eur Rev Med Pharmacol Sci,2014 , 18 ( 22 ) :3497 - 3503.
  • 5Liu S, Zhou J, Wen J. Expression and significance of CD133 and AB- CG2in endometriosis[ J]. Clinical and Experimental Obstetrics & Gy- necology, 2015, 42(6) :771 - 775.
  • 6Sampson JA. Endometrial carcinoma of the ovary arising in endomctrial Tissue in that organ [ J ]. Arch Surg, 1925,10 ( 1 ) : 1 - 12.
  • 7Scott RB. Malignant changesin endometriosis [ J ]. Obstet Gynecol, 1953,2 (3) :283 - 289.
  • 8Davis M, Rauh - Hain JA, Andrade C, et al. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary [J]. Gynecol Oncol,2014, 132(3) :760 -766.
  • 9Matsumoto T, Yamazaki M,Takahashi H, et al. Distinct β -catenin and PIK3CA mutation profiles in endometriosis - associated ovarian endometrioid and clear cell carcinomas[J]. Am J Clin Pathol,2015, 144(3) :452 -463.
  • 10Ren F, Wang DB, Li T, et al. Identification of differentially methyla- ted genes in the malignant transformation of ovarian endometriosis [ J ]. J Ovarian Res, 2014,7:73.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部